IDEAYA Biosciences (IDYA) EBIT Growth (1y) (2019 - 2026)
Powered by 
Analysis
IDEAYA Biosciences (IDYA) EBIT Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 8.32% |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 19.82% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 145.20% |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 10.14% |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 269.85% |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 1,528.74% |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | -36.55% |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 99.51% |
| 10 | IDEAYA Biosciences | 3.66 Bn | 2.83 Bn | - | -37.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -37.71% |
| Mar 31, 2026 | -28.62% |
| Dec 31, 2025 | 34.39% |
| Sep 30, 2025 | 262.13% |
| Jun 30, 2025 | -36.78% |
| Mar 31, 2025 | -65.41% |
| Dec 31, 2024 | -243.87% |
| Sep 30, 2024 | -99.53% |
| Jun 30, 2024 | -98.50% |
| Mar 31, 2024 | -94.14% |
| Dec 31, 2023 | -58.52% |
| Sep 30, 2023 | -5,179.70% |
| Jun 30, 2023 | -45.38% |
| Mar 31, 2023 | -84.80% |
| Dec 31, 2022 | -43.95% |
| Sep 30, 2022 | 105.63% |
| Jun 30, 2022 | -103.59% |
| Mar 31, 2022 | -55.67% |
| Dec 31, 2021 | -247.90% |
| Sep 30, 2021 | -134.45% |